市場調查報告書

G-CSF (顆粒細胞增生因子)生物相似藥的全球市場 - 市場規模調查及地區別未來預測

Global G-CSF Biosimilars Market Size study, by Type, By Application and Regional Forecasts 2018-2025

出版商 Bizwit Research & Consulting LLP 商品編碼 784418
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
G-CSF (顆粒細胞增生因子)生物相似藥的全球市場 - 市場規模調查及地區別未來預測 Global G-CSF Biosimilars Market Size study, by Type, By Application and Regional Forecasts 2018-2025
出版日期: 2019年01月25日內容資訊: 英文
簡介

本報告涵括G-CSF (顆粒細胞增生因子)生物相似藥的全球市場,透過市場成長促進因素和課題,市場趨勢,以及市場競爭情形的廣泛調查,來進行市場現狀分析以及未來預測。同時更提供市場各類型,各適應症,及各地區類別之各部門詳細的分析與預測。

第1章 摘要整理

  • 市場概況
  • 主要趨勢
  • 全球市場及各領域市場預算及未來預測
  • 預算手法
  • 調查上的估計條件

第2章 G-CSF生物相似藥市場定義和範圍

  • 本調查的目的
  • 市場定義及範圍
  • 調查對象年
  • 貨幣替換比率

第3章 G-CSF生物相似藥市場動態

  • Seesaw分析
    • 市場成長促進因素
    • 市場課題
    • 市場機會

第4章 G-CSF生物相似藥市場產業分析

  • 波特的五力分析模型
  • PEST分析
  • 價值鏈分析
  • 主要購買標準
  • 相關法規
  • 成本結構分析
  • 投資 vs 採用度方案
  • 分析師的建議與結論

第5章 G-CSF生物相似藥市場各類型分析

  • 市場概況
  • 市場實際成果 - 未來性模式
  • 主要企業
  • G-CSF生物相似藥市場各類型分析
    • 人體生長荷爾蒙
    • 促血紅細胞生長素
    • 單株抗體
    • 胰島素
    • 干擾素
    • 顆粒細胞增生因子

第6章 G-CSF生物相似藥市場各適應症分析

  • 市場概況
  • 市場實際成果 - 未來性模式
  • 主要企業
  • G-CSF生物相似藥市場各適應症分析
    • 血液疾病
    • 腫瘤性疾病
    • 慢性病及自體免疫疾病
    • 生長激素缺乏症

第7章 G-CSF生物相似藥市場各地區分析

  • G-CSF生物相似藥市場各地區市場概況
  • 北美的G-CSF生物相似藥市場概況
    • 美國
    • 加拿大
  • 歐洲的G-CSF生物相似藥市場概況
    • 英國
    • 德國
    • 法國
    • 其他歐洲各國
  • 亞洲的G-CSF生物相似藥市場概況
    • 中國
    • 印度
    • 日本
    • 其他的亞太地區各國
  • 南美的G-CSF生物相似藥市場概況
    • 巴西
    • 墨西哥
  • 其他地區
    • 南美
    • 中東及非洲

第8章 市場競爭資訊

  • 各企業市場佔有率
  • 最重要市場策略
  • 企業簡介
    • Pfizer
    • Novartis
    • Roche
    • Merck & Co.
    • Sanofi
    • Johnson & Johnson
    • Gilead Science
    • GlaxoSmithKline
    • AbbVie
    • Amgen
    • AstraZeneca
    • Bayer

第9章 調查流程

目錄

Global G-CSF Biosimilars Market to reach USD XX billion by 2025.

Global G-CSF Biosimilars Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The G-CSF Biosimilars Market is continuously growing across the world over the coming years. Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. GCSF stimulates granulocyte production in BM suppressed by chemotherapy and radiotherapy and reduces infections in cancer patients. It can induce terminal maturation of myeloid leukemia cells, resulting in complete hematologic and cytologic remission, and can suppress self-renewal. It is useful in patients with AIDS or leukemic relapse after allogeneic BM transplantation. Increasing aging population, growing incidence of chronic diseases and rising healthcare expenditure are the substantial driving factors of the market across the globe. In addition, growing acceptance due to their cost-effectiveness is also boosting the market growth over the upcoming years. Furthermore, patent expiry of biologic products is the major factor which creating numerous opportunity in the market over the coming years. However, complications associated with manufacturing of G-CSF biosimilars are the factors which limiting the market growth of G-CSF Biosimilars over the coming years. The regional analysis of Global G-CSF Biosimilars Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.

The major market player included in this report are:

  • Pfizer
  • Novartis
  • Roche
  • Merck & Co.
  • Sanofi
  • Johnson & Johnson
  • Gilead Science
  • GlaxoSmithKline
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Human Growth Hormone
  • Erythropoietin
  • Monoclonal Antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor

By Application:

  • Blood Disorders
  • Oncology Diseases
  • Chronic and Autoimmune Diseases
  • Growth Hormone Deficiencies

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2015, 2016

Base year - 2017

Forecast period - 2018 to 2025

Target Audience of the Global G-CSF Biosimilars Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. G-CSF Biosimilars Market, by Type, 2015-2025 (USD Billion)
    • 1.3.2. G-CSF Biosimilars Market, by Application, 2015-2025 (USD Billion)
    • 1.3.3. G-CSF Biosimilars Market, by Region, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. G-CSF Biosimilars Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. G-CSF Biosimilars Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. G-CSF Biosimilars Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Value Chain Analysis
    • 4.3.1. Supplier
    • 4.3.2. Manufacturers/Service Provider
    • 4.3.3. Distributors
    • 4.3.4. End-Users
  • 4.4. Key Buying Criteria
  • 4.5. Regulatory Framework
  • 4.6. Cost Structure Analysis
    • 4.6.1. Raw Material Cost Analysis
    • 4.6.2. Manufacturing Cost Analysis
    • 4.6.3. Labor Cost Analysis
  • 4.7. Investment Vs Adoption Scenario
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. G-CSF Biosimilars Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. G-CSF Biosimilars Market, Sub Segment Analysis
    • 5.4.1. Human Growth Hormone
      • 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.2. Erythropoietin
      • 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.3. Monoclonal Antibodies
      • 5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.4. Insulin
      • 5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.5. Interferon
      • 5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.6. Granulocyte-Colony Stimulating Factor
      • 5.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. G-CSF Biosimilars Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. G-CSF Biosimilars Market, Sub Segment Analysis
    • 6.4.1. Blood Disorders
      • 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.2. Oncology Diseases
      • 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.3. Chronic and Autoimmune Diseases
      • 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.4. Growth Hormone Deficiencies
      • 6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. G-CSF Biosimilars Market, by Regional Analysis

  • 7.1. G-CSF Biosimilars Market, Regional Market Snapshot (2015-2025)
  • 7.2. North America G-CSF Biosimilars Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.3. Europe G-CSF Biosimilars Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. France
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.4. Rest of Europe
      • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.4. Asia G-CSF Biosimilars Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.5. Latin America G-CSF Biosimilars Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Pfizer
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Novartis
    • 8.3.3. Roche
    • 8.3.4. Merck & Co.
    • 8.3.5. Sanofi
    • 8.3.6. Johnson & Johnson
    • 8.3.7. Gilead Science
    • 8.3.8. GlaxoSmithKline
    • 8.3.9. AbbVie
    • 8.3.10. Amgen
    • 8.3.11. AstraZeneca
    • 8.3.12. Bayer

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF G-CSF BIOSIMILARS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF G-CSF BIOSIMILARS MARKET
  • TABLE 3. G-CSF BIOSIMILARS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD BILLION)
  • TABLE 8. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
  • TABLE 9. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. G-CSF BIOSIMILARS MARKET, RESEARCH METHODOLOGY
  • FIG 2. G-CSF BIOSIMILARS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. G-CSF BIOSIMILARS MARKET, KEY TRENDS 2016
  • FIG 5. G-CSF BIOSIMILARS MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. G-CSF BIOSIMILARS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. G-CSF BIOSIMILARS MARKET, PEST ANALYSIS
  • FIG 8. G-CSF BIOSIMILARS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. G-CSF BIOSIMILARS MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 36. G-CSF BIOSIMILARS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
Back to Top